Recently, Bairral et al. (1) described the interesting case of a 20-year-old female patient who attempted suicide by ingesting lead shot. She was treated with atropine and received 50 g of activated charcoal (AC) diluted in 400 mL of mannitol administered through a gastric tube. A few hours later, the patient vomited, as well as experiencing a decreased level of consciousness and agonal respiration. At bronchoscopy, blackish material mixed with food debris was obtained, characterizing the occurrence of aspiration of the material. Imaging studies revealed bilateral alveolar opacities.
We would like to report our experience of a case of attempted suicide in which the pulmonary and pleural complications were due not to aspiration, but to direct instillation of AC into the airways. The patient was a 23-year-old female who was admitted to the hospital approximately one hour and a half after the ingestion of 200 mg of paroxetine. Upon her arrival, she was in a coma and underwent gastric lavage with a solution of 1.5 L of AC. The patient immediately developed dry cough and dyspnea. A chest X-ray showed right pleural effusion, and, during thoracentesis, there was discharge of black fluid, identified as AC ( Figure 1) . A CT scan showed pleural effusion and consolidation in the right lower lobe, both of which exhibited high density (attenuation values of approximately 130 HU), as well as pneumothorax ( Figure 2 ). These findings raised the suspicion of direct instillation of AC into the lungs due to placement of the nasogastric tube within the patient's airway. At bronchoscopy, there was discharge of black material from the right lower lobe. An air leak was noted from the chest tube, suggesting bronchopleural fistula. The patient underwent thoracoscopy and pleural lavage. Fifteen days later, the fistula closed, and the patient was discharged from the hospital.
Some of the data on this case have been reported in a previous publication. (2) Most of the complications related to treatment with AC result from aspiration of gastric content, as has been reported by Bairral et al., (1) rather than from direct aspiration of AC. Occasionally, the nasogastric tube can be mistakenly inserted into the trachea, and there can occur direct administration of AC into the airways. Another complication related to direct instillation of charcoal into the airways is pleural involvement. Findings of pleural effusion, presence of charcoal in the collected fluid, and pneumothorax associated with bronchopleural fistula are probably secondary to instillation of a large amount of AC solution into the distal airways. (3) Pleural rupture caused by the nasogastric tube, rupture of a subpleural bulla after aspiration (with consequent development of a bronchopleural fistula), and perforation of the esophagus, with formation of an esophagopleural fistula, are possible mechanisms for pleural involvement. (4) The incidence of inadvertent insertion of the nasogastric tube into the trachea and the distal airways ranges from 0.3% to 15%.
(5) Physical examination is often not a good predictor of incorrect positioning of the tube, especially in unconscious patients. In general, the positioning of the tube is initially assessed by fluid aspiration or by air insufflation and auscultation of the abdomen. These maneuvers can provide falsepositive results. (6) The position of the tube should be verified radiographically before the administration of AC. (3) In conclusion, in patients treated with AC, a CT finding of high-density material in the lung parenchyma or the pleural cavity is strongly suggestive of accidental instillation of the product into the airways. 
